1 Department of Pediatrics and Obstetrics and Gynecology, University of Tennessee, Memphis, Memphis, TN 38163
Periventricular-intraventricular hemorrhage (IVH) remains a significant cause of long-term morbidity among premature infants1. Clinical trials2-4 have shown that prophylactic indomethacin is associated with a decreased incidence of IVH, including the severe form. In this issue of Pediatrics, Ment et al5 report on the long-term outcome of children who received indomethacin prophylaxis for IVH. Incidence of cerebral palsy (8%) was similar between the indomethacin-and placebo-treated groups; mean IQ scores determined from the Stanford-Binet Intelligence Scale (Form L-M, 1972) did not differ. IQ scores were significantly related to IVH, birth weight, and maternal education; ie, lower IQ scores with IVH and higher scores with higher birth weight and years of education.
Submitted on July 11, 1996
This article has been cited by other articles:
![]() |
B. Schmidt, P. Davis, D. Moddemann, A. Ohlsson, R. S. Roberts, S. Saigal, A. Solimano, M. Vincer, L. L. Wright, and the Trial of Indomethacin Prophylaxis in Preterms Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants N. Engl. J. Med., June 28, 2001; 344(26): 1966 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Bada Prevention of Intracranial Hemorrhage NeoReviews, March 1, 2000; 1(3): e48 - 52. [Full Text] |
||||